Premium Membership
2010
29th
July 6:49am

NASDAQ oscillations in review: (AVII, HAFC, URRE, ESLR, SNSS)


Dear PSL members,

NASDAQ oscillations in review: (AVII, HAFC, URRE, ESLR, SNSS)

AVI BioPharma, Inc. (NASDAQ: AVII) surged by 2.70% to close at $1.9 with traded volume of 1.67 million shares. AVI BioPharma, Inc. (AVI) is a biopharmaceutical company specializing in the discovery and development of ribonucleic acid (RNA) based drugs targeting a range of diseases. The Company’s core chemistry is based on phosphordiamidate-linked morpholino oligomers (PMOs). PMOs are synthetic molecules based on a fundamental redesign of the natural nucleic acid structure of deoxyribonucleic acid (DNA) and RNA. Translation Suppressing Oligomers (TSOs) are PMO-based antisense compounds that interfere with gene expression and other RNA-dependent cellular processes by binding to their specific target sequence in RNA. Splice Switching Oligomers (SSOs) are PMO-based compounds that can direct alternative splicing by forcing the cellular splicing machinery towards desired splicing outcomes, such as promoting the expression of a messenger RNA (mRNA) for desired protein.

Hanmi Financial Corp (NASDAQ: HAFC) closed at $1.22 with no change for the day whereas total traded volume stood at 1.52 million shares.

Uranium Resources, Inc. (NASDAQ: URRE) went up by 12.77% and closed at $0.53 with traded volume of 1.49 million shares in the last trading day. Uranium Resources, Inc. (URI) is a uranium exploration, mine development and production company. It is engaged in acquiring and developing uranium mines in South Texas using the in-situ recovery mining process (ISR). URI has produced approximately 8 million pounds U3O8 from five Texas projects, two of which have been fully restored and returned to the land owners. The Company has two fully licensed ISR processing facilities in Texas, Kingsville Dome and Rosita as of December 31, 2009. As of December 31, 2009, the Company owns both producing and undeveloped uranium properties in South Texas and undeveloped uranium properties in New Mexico.

Evergreen Solar, Inc. (NASDAQ: ESLR) closed at $0.7 with no change for the day whereas traded volume stood at 1.12 million shares. Evergreen Solar, Inc. develops, manufactures and markets String Ribbon solar panels, utilizing its wafer manufacturing technology. The wafers the Company produces are the primary components of photovoltaic (PV) cells which, in turn, are used to produce solar panels. The Company sells its products using distributors, systems integrators and other resellers. The Company’s products are sold to customers primarily in Europe and the United States. The Company develops, manufactures and markets solar power products, including solar cells, panels and systems. The Company’s solar panels include wafers, cells and panels. A crystalline silicon wafer is a flat piece of crystalline silicon that can be processed and assembled into a solar cell. Its rectangular wafers measure approximately 80 millimeters by 150 millimeters and are approximately 190 microns thick. A solar cell is a device made from a silicon wafer that converts sunlight into electricity by means of a process known as the PV effect.

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) closed at $0.48 with no change whereas overall traded volume stood at 970,965 shares. Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. The Company focuses primarily on the development of voreloxin for the treatment of acute myeloid leukemia (AML). It owns global development and commercialization rights to voreloxin and are preparing for the Phase III development of the compound. In March 2009, the Company announced the sale of its interest in all of the lymphocyte function-associated antigen-1, or LFA-1.

***********************

Limited Time Offer:

  • We are offering only 200 more spots to join our Premium Subscribers Listfor only $9.99 per month for a lifetime guarantee on that price.
  • So what happens to the 201st premium subscriber and thereafter, you will be paying $49.99 per month.
  • We have been in long discussions and we have decided to raise our rates on our subscribers that apply to our list after the 200th person.
  • For those of you who are our current subscribers and the next 200 subscribers…will keep their price of $9.99 for a lifetime guarantee. We are not raising rates for you.
  • The reason we have decided to raise our rates to $49.99 is due to the growing demand in our services, and the overall great success that we have achieved with almost all of our picks.

Click HERE to subscribe through PayPal for $9.99 a month for next 200 subscribers…

************************

Happy trading,

PSL staff, www.PennyStockLive.com

Tags: , , , ,